A Gene-Edited Vaccine Against Malaria - Dr. Stefan Kappe
Malaria is a deadly, mosquito-vectored disease in areas of the Developing World. Intensive efforts have resulted in few effective prophylactic or therapeutic practices or products that are without serious limitations. A vaccine against the causative organ
Talking Biotech with Dr. Kevin Folta · Colabra
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
The mosquito is the most deadly animal on earth. It vectors a plasmodium, a eukaryotic parasite that invades the liver of the host and ultimately attacks red blood cells. There are some therapies and preventatives, but a durable vaccine would be a game changer in the Developing World. Dr. Stefan Kappe and his team have developed a vaccine based on the weakened plasmodium parasite. They used CRISPR/Cas9 gene editing to disrupt genes required for life cycle progression, so the vaccinated can receive a vaccination and invoke a strong immunological response against the actual pathogen if encountered. Clinical trials have demonstrated safety and efficacy, and paved the way for even more effective approaches that may be significant public health advances throughout the Developing World.
Link to Dr. Kappe's Laboratory
Link to the accompanying paper here.